DE602004020381D1 - Butylphthalid-enthaltende weichgelkapsel und prozess ihrer herstellung - Google Patents

Butylphthalid-enthaltende weichgelkapsel und prozess ihrer herstellung

Info

Publication number
DE602004020381D1
DE602004020381D1 DE602004020381T DE602004020381T DE602004020381D1 DE 602004020381 D1 DE602004020381 D1 DE 602004020381D1 DE 602004020381 T DE602004020381 T DE 602004020381T DE 602004020381 T DE602004020381 T DE 602004020381T DE 602004020381 D1 DE602004020381 D1 DE 602004020381D1
Authority
DE
Germany
Prior art keywords
butylphthalide
capsule
soft capsule
manufacture
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004020381T
Other languages
English (en)
Inventor
Jianqing Li
Min Bai
Wenmin Guo
Surui Chen
Liyun Liu
Guirong Zhou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSPC NBP Pharmaceutical Co Ltd
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Original Assignee
CSPC NBP Pharmaceutical Co Ltd
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSPC NBP Pharmaceutical Co Ltd, CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd filed Critical CSPC NBP Pharmaceutical Co Ltd
Publication of DE602004020381D1 publication Critical patent/DE602004020381D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Formation And Processing Of Food Products (AREA)
DE602004020381T 2003-12-05 2004-12-03 Butylphthalid-enthaltende weichgelkapsel und prozess ihrer herstellung Active DE602004020381D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2003101193361A CN1257711C (zh) 2003-12-05 2003-12-05 丁苯酞软胶囊及其制备工艺
PCT/CN2004/001411 WO2005053658A1 (fr) 2003-12-05 2004-12-03 Capsule molle de butylphthalide et procede de preparation correspondant

Publications (1)

Publication Number Publication Date
DE602004020381D1 true DE602004020381D1 (de) 2009-05-14

Family

ID=34638049

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004020381T Active DE602004020381D1 (de) 2003-12-05 2004-12-03 Butylphthalid-enthaltende weichgelkapsel und prozess ihrer herstellung

Country Status (15)

Country Link
US (4) US20080020034A1 (de)
EP (1) EP1702612B1 (de)
JP (1) JP4634394B2 (de)
KR (1) KR100761437B1 (de)
CN (1) CN1257711C (de)
AT (1) ATE427104T1 (de)
AU (1) AU2004294254B2 (de)
BR (1) BRPI0417339C8 (de)
CA (1) CA2549498C (de)
DE (1) DE602004020381D1 (de)
HK (1) HK1090302A1 (de)
MX (1) MXPA06006401A (de)
NO (1) NO338520B1 (de)
RU (1) RU2322976C1 (de)
WO (1) WO2005053658A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100471494C (zh) * 2005-12-24 2009-03-25 石药集团中奇制药技术（石家庄）有限公司 丁苯酞滴丸及制备方法
KR101393944B1 (ko) * 2006-01-24 2014-05-12 수캄포 아게 연질-젤라틴 캡슐 제형물
CN101342152B (zh) * 2007-07-10 2010-10-13 石药集团中奇制药技术（石家庄）有限公司 丁苯酞片及其制备方法
US8726005B2 (en) 2009-12-10 2014-05-13 George Mason Intellectual Properties, Inc. Website matching based on network traffic
CN102058560B (zh) * 2010-12-30 2013-07-24 张家界茅岩莓有限公司 一种二氢杨梅素软胶囊及制备方法
CN102178643B (zh) * 2011-04-29 2014-05-14 石药集团恩必普药业有限公司 一种丁苯酞或其衍生物的微乳透皮凝胶剂及其制备方法
CN103169685B (zh) * 2011-12-23 2018-03-06 石药集团中奇制药技术（石家庄）有限公司 一种丁苯酞控释制剂及其制备方法
CN102716121B (zh) * 2012-06-06 2017-10-24 石药集团中奇制药技术（石家庄）有限公司 一种丁苯酞药物活性组合物及其制备方法
CN102716103B (zh) * 2012-07-02 2013-12-18 西安力邦制药有限公司 2,2′,6,6′-四异丙基-4,4′-二联苯酚软胶囊制剂及其制备方法
CN104224772A (zh) * 2013-06-13 2014-12-24 石药集团中奇制药技术（石家庄）有限公司 一种包含丁苯酞和冰片的药物组合物及其应用
CN106606498A (zh) * 2016-07-25 2017-05-03 山东诚创医药技术开发有限公司 一种丁苯酞软胶囊
CN106580959B (zh) * 2017-01-10 2019-04-23 山东省立医院 一种缓解急性缺血性脑卒中的丁苯酞尼群地平软胶囊
CN109432042B (zh) * 2018-12-24 2022-04-22 石药集团恩必普药业有限公司 一种软胶囊囊壳及其制备方法
CN112336700B (zh) * 2019-08-08 2023-12-01 河北菲尼斯生物技术有限公司 一种稳定的含丁苯酞药物及其制备方法
CN114073694B (zh) * 2020-08-14 2024-03-12 北京科莱博医药开发有限责任公司 丁苯酞制剂及其制备方法
KR102294072B1 (ko) 2020-11-19 2021-08-26 (주)알피바이오 식물성 츄어블 연질캡슐용 조성물 및 이를 통해 형성된 식물성 츄어블 연질캡슐
KR102523186B1 (ko) 2020-11-19 2023-04-18 (주)알피바이오 동물성 츄어블 연질캡슐용 조성물 및 이를 통해 형성된 동물성 츄어블 연질캡슐
CN113975242A (zh) * 2021-10-14 2022-01-28 山东诚创蓝海医药科技有限公司 一种提高口服生物利用度的丁苯酞软胶囊
CN115453014B (zh) * 2022-10-28 2024-04-19 成都施贝康生物医药科技有限公司 一种丁苯酞及其有关物质的检测方法
CN115469039B (zh) * 2022-10-28 2024-04-26 成都施贝康生物医药科技有限公司 一种丁苯酞及其有关物质检测方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3927195A (en) * 1974-01-31 1975-12-16 Lilly Industries Ltd Production of capsules
NL7510104A (nl) * 1975-08-27 1977-03-01 Akzo Nv Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.
US4366145A (en) * 1981-06-24 1982-12-28 Sandoz, Inc. Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
AU552068B2 (en) * 1981-09-21 1986-05-22 Asama Chemical Co. Ltd. Preservation of edible oils
FR2608456B1 (fr) * 1986-12-18 1993-06-18 Mero Rousselot Satia Microcapsules a base de gelatine et de polysaccharides et leur procede d'obtention
JPH01199958A (ja) * 1987-07-23 1989-08-11 Tsumura & Co 新規なフタリド誘導体およびその製造方法
CN1129908A (zh) 1993-06-25 1996-08-28 美因坎普营销私人有限公司 治疗剂
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
AUPO990397A0 (en) * 1997-10-22 1997-11-13 R.P. Scherer Holdings Pty Ltd Clear solutions of herbal extracts
CN1086942C (zh) * 1998-12-18 2002-07-03 中国医学科学院药物研究所 丁基苯酞在制备抗血栓形成及抗血小板聚集药物中的应用
US6800329B2 (en) * 1999-02-12 2004-10-05 Lts Lohmann Therapie-Systeme Ag Method for producing film-type dosage
US6193999B1 (en) * 1999-03-01 2001-02-27 Banner Pharmacaps, Inc. Gum acacia substituted soft gelatin capsules
CN1102397C (zh) * 2000-03-01 2003-03-05 山东绿叶制药股份有限公司 当归油软胶囊及其制备工艺
CN1375288A (zh) * 2002-05-13 2002-10-23 周桂荣 一种治疗脑血管疾病的药物组合物
ATE489972T1 (de) * 2002-08-21 2010-12-15 Shijiazhuang Pharma Group Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd Einschlusskomplexe aus butylphthalid und cyclodextrin derivaten und verfahren zu deren herstellung

Also Published As

Publication number Publication date
CA2549498A1 (en) 2005-06-16
BRPI0417339B1 (pt) 2017-12-19
NO338520B1 (no) 2016-08-29
BRPI0417339B8 (pt) 2020-06-02
RU2322976C1 (ru) 2008-04-27
BRPI0417339C1 (pt) 2021-05-25
CN1623542A (zh) 2005-06-08
US20070134316A1 (en) 2007-06-14
JP4634394B2 (ja) 2011-02-16
KR20060105013A (ko) 2006-10-09
EP1702612B1 (de) 2009-04-01
BRPI0417339A (pt) 2007-02-21
AU2004294254B2 (en) 2008-02-07
WO2005053658A1 (fr) 2005-06-16
BRPI0417339C8 (pt) 2022-02-01
HK1090302A1 (en) 2006-12-22
JP2007513097A (ja) 2007-05-24
KR100761437B1 (ko) 2007-10-04
NO20062895L (no) 2006-09-04
US8609137B2 (en) 2013-12-17
US20080305163A1 (en) 2008-12-11
RU2006122207A (ru) 2008-01-10
ATE427104T1 (de) 2009-04-15
WO2005053658A8 (fr) 2005-10-13
EP1702612A4 (de) 2006-12-20
AU2004294254A1 (en) 2005-06-16
EP1702612A1 (de) 2006-09-20
MXPA06006401A (es) 2007-11-13
CN1257711C (zh) 2006-05-31
CA2549498C (en) 2011-07-12
US20120052117A1 (en) 2012-03-01
US20080020034A1 (en) 2008-01-24

Similar Documents

Publication Publication Date Title
HK1090302A1 (en) Soft capsule containing butylphthalide and its preparation procedure
RS50937B (sr) Farmaceutska kompozicija koja sadrži metformin i glibenklamid za lečenje šećerne bolesti tipa ii
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
HUP0202495A2 (hu) Orális alkalmazásra szolgáló stabil gyógyszerkészítmény
EA200500891A1 (ru) Фармацевтические композиции, содержащие щелочные или соответственно кислые лекарственные соединения, поверхностно-активное вещество и физиологически приемлемую водорастворимую кислоту или соответственно основание
BR0212921A (pt) Composição farmacêutica com base em fondant
EE05301B1 (et) Meetod epotilooni analooge sisaldavate ravimvormide valmistamiseks ning nende kasutamine ravimi valmistamiseks
WO2009113051A3 (en) Oral modified-release formulations containing thiazepines
ATE462410T1 (de) Selbstemulgierendes butylbenzolphthalein- arzneimittelabgabesystem, sein herstellungsverfahren und seine anwendung
ATE387937T1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer und hydroxynaphthalin-carbonsäure, sowie deren herstellung
DE50112438D1 (de) Zahnpflegemittel in portionskapseln
ATE301990T1 (de) Pharmazeutische desmopressin-zubereitung als feste darreichungsform und methode zu ihrer herstellung
AR021086A1 (es) Omega-amidas de n-arilsulfonil-aminoacidos, un procedimiento para su preparacion, medicamento, uso de dichos compuestos para la preparacion de un medicamento y procedimiento para la preparacion de un medicamento.
CH701478B1 (it) Formulazioni solide contenenti farmaci dimagranti
MXPA04003506A (es) Metodo para la preparacion de una composicion farmaceutica que comprende acido 5-aminosalicilico para el uso en el tratamiento de la colitis ulcerativa y de la enfermedad de crohn.
WO2004071156A3 (en) Use of edible acid in fast-dispersing pharmaceutical solid dosage forms
HUP0303178A2 (hu) Eljárások és készítmények gyógyászatilag aktív anyagok ízének csökkentésére
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
ATE286893T1 (de) 2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
WO2002011668A3 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
UY27376A1 (es) Formulación de medicamento que contiene un antagonista de ltb4
WO2004069832A3 (en) Antibacterial agents
CN104435010A (zh) 一种复方干粉剂及其制备方法
TH20330B (th) สูตรผสมเภสัชกรรมของเซฟาคลอร์

Legal Events

Date Code Title Description
8364 No opposition during term of opposition